Yeole B B, Jussawalla D J
Bombay Cancer Registry, Mumbai.
Indian J Cancer. 1998 Sep;35(3):101-6.
Bone tumours are comparatively uncommon, constituting only 0.5% of the total world cancer incidence. As Bone tumors consist of several distinct clinico-pathological entities, descriptive epidemiology of tumors at this site can be based only on studies where they can be distinguished. Ewing's sarcoma Chondrosarcoma and Osteosarcoma are the principal tumors involving bones. The basic data utilized for this study was collected from the Bombay Cancer Registry which was established in 1963, and is the first population based registry to be established in India. For studying the descriptive epidemiological variables the most recent 5 year incidence rates have been used. As a group, bone cancers represent 0.9% of the total number of incident cancer are seen in Greater Bombay. Males in general are seen to have a higher incidence of bone cancers than females. Ewing's sarcoma was found to be the commonest bone cancer in Bombay. The age specific incidence curves present striking differences according to cell types of bone cancer. Time trends in the incidence of these cancers, over the past 30 years have been presented. Our data indicate that there is a decreasing trend in incidence of bone cancers in females, whilst the rates are stable in males. Ionising radiation is the only environmental agent to cause this cancer. The discovery of other risk factors is the key prevention and will depend upon the experimental work undertaken to develop sub-clinical measures of risk that can be applied in interdisciplinary studies to identify more completely the causes of bone cancers.
骨肿瘤相对少见,仅占全球癌症总发病率的0.5%。由于骨肿瘤由几种不同的临床病理实体组成,该部位肿瘤的描述性流行病学只能基于能够区分它们的研究。尤因肉瘤、软骨肉瘤和骨肉瘤是累及骨骼的主要肿瘤。本研究使用的基础数据来自于1963年建立的孟买癌症登记处,它是印度建立的第一个基于人群的登记处。为了研究描述性流行病学变量,使用了最近5年的发病率。总体而言,骨癌占大孟买地区癌症发病总数的0.9%。一般来说,男性骨癌的发病率高于女性。尤因肉瘤被发现是孟买最常见的骨癌。根据骨癌的细胞类型,年龄特异性发病率曲线呈现出显著差异。本文呈现了过去30年这些癌症发病率的时间趋势。我们的数据表明,女性骨癌发病率呈下降趋势,而男性发病率稳定。电离辐射是导致这种癌症的唯一环境因素。发现其他风险因素是预防的关键,这将取决于为开发可应用于跨学科研究以更全面地确定骨癌病因的亚临床风险测量方法而开展的实验工作。